Mayo Stephen

Mayo Stephen is listed in filings as Director at Sarepta Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including sale activity. Recent filings connect the profile to Sarepta Therapeutics, Inc. (SRPT), Merck & Co (2020 Irrev Trust FBO Grandchildren) (MRK), and Allogene Therapeutics, Inc. (ALLO). The current snapshot covers public activity from Mar 11, 2025 to Jun 5, 2026. Reported amounts are shown as $123.2K to $477.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.